🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/10/2011 | 42,11 | 42,41 | 41,30 | 41,37 | -1,94% | 2,64% | 702.500 |
| 24/10/2011 | 40,79 | 42,36 | 40,69 | 42,19 | +3,79% | 4,09% | 1.137.500 |
| 21/10/2011 | 40,87 | 41,66 | 40,13 | 40,65 | +0,12% | 3,74% | 1.660.700 |
| 20/10/2011 | 39,72 | 40,67 | 39,22 | 40,60 | +2,47% | 3,65% | 1.156.400 |
| 19/10/2011 | 40,02 | 40,55 | 39,49 | 39,62 | -1,05% | 2,65% | 1.078.300 |
| 18/10/2011 | 39,12 | 40,29 | 38,85 | 40,04 | +2,19% | 3,68% | 1.829.000 |
| 17/10/2011 | 40,00 | 40,28 | 39,09 | 39,18 | -2,37% | 2,97% | 1.742.900 |
| 14/10/2011 | 39,98 | 40,22 | 39,25 | 40,13 | +0,96% | 2,43% | 1.035.800 |
| 13/10/2011 | 39,20 | 39,78 | 38,61 | 39,75 | +0,79% | 2,98% | 1.289.100 |
| 12/10/2011 | 40,05 | 40,74 | 39,28 | 39,44 | -0,75% | 3,65% | 6.703.600 |
| 11/10/2011 | 38,36 | 40,29 | 37,59 | 39,74 | +4,97% | 7,04% | 4.172.500 |
| 10/10/2011 | 37,88 | 38,07 | 37,54 | 37,86 | +1,50% | 1,40% | 1.113.200 |
| 07/10/2011 | 38,14 | 38,45 | 37,08 | 37,30 | -1,71% | 3,59% | 1.565.100 |
| 06/10/2011 | 37,88 | 38,26 | 37,57 | 37,95 | +0,26% | 1,82% | 1.377.400 |
| 05/10/2011 | 37,43 | 38,00 | 37,09 | 37,85 | +1,10% | 2,43% | 2.347.200 |
| 04/10/2011 | 37,00 | 37,54 | 36,55 | 37,44 | +0,62% | 2,68% | 1.802.300 |
| 03/10/2011 | 37,16 | 38,01 | 36,80 | 37,21 | -0,75% | 3,26% | 1.753.500 |
| 30/09/2011 | 37,32 | 37,75 | 37,01 | 37,49 | +0,05% | 1,98% | 1.202.800 |
| 29/09/2011 | 38,34 | 38,34 | 36,83 | 37,47 | -0,98% | 3,94% | 1.709.900 |
| 28/09/2011 | 39,33 | 39,59 | 37,60 | 37,84 | -3,40% | 5,06% | 1.442.000 |
| 27/09/2011 | 39,07 | 39,60 | 38,60 | 39,17 | +2,14% | 2,56% | 1.615.600 |
| 26/09/2011 | 40,60 | 40,60 | 37,20 | 38,35 | -5,80% | 8,37% | 3.886.400 |
| 23/09/2011 | 40,05 | 40,78 | 39,99 | 40,71 | +2,16% | 1,97% | 1.124.300 |
| 22/09/2011 | 39,71 | 40,48 | 39,36 | 39,85 | -0,85% | 2,82% | 1.805.700 |
| 21/09/2011 | 42,28 | 42,59 | 40,18 | 40,19 | -4,74% | 5,70% | 1.052.500 |
| 20/09/2011 | 43,21 | 43,46 | 42,04 | 42,19 | -1,49% | 3,29% | 916.100 |
| 19/09/2011 | 43,23 | 43,40 | 42,46 | 42,83 | -1,72% | 2,17% | 1.190.100 |
| 16/09/2011 | 44,25 | 44,71 | 43,38 | 43,58 | -1,29% | 3,01% | 1.406.100 |
| 15/09/2011 | 43,87 | 44,40 | 43,26 | 44,15 | -0,29% | 2,60% | 1.186.600 |
| 14/09/2011 | 44,19 | 44,69 | 43,66 | 44,28 | +0,82% | 2,33% | 1.107.300 |